SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-19-003621
Filing Date
2019-11-14
Accepted
2019-11-14 15:29:36
Documents
64
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cannapharmarx_10q-09302019.htm 10-Q 565982
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER cannapharmarx_ex3101.htm EX-31.1 11246
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER cannapharmarx_ex3102.htm EX-31.2 11280
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER cannapharmarx_ex3200.htm EX-32 4967
  Complete submission text file 0001683168-19-003621.txt   2990655

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cpmd-20190930.xml EX-101.INS 458357
6 XBRL SCHEMA FILE cpmd-20190930.xsd EX-101.SCH 32578
7 XBRL CALCULATION FILE cpmd-20190930_cal.xml EX-101.CAL 56672
8 XBRL DEFINITION FILE cpmd-20190930_def.xml EX-101.DEF 130836
9 XBRL LABEL FILE cpmd-20190930_lab.xml EX-101.LAB 248069
10 XBRL PRESENTATION FILE cpmd-20190930_pre.xml EX-101.PRE 209059
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

IRS No.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27055 | Film No.: 191219507
SIC: 2834 Pharmaceutical Preparations